Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines

Molecular and Cellular Biology

Volumn 18, Issue 8, 1998, Pages 4719-4731

  Li, Yin ^a   Lin, Bingzhen ^a   Agadir, Anissa ^a   Liu, Ru ^a   Dawson, Marcia I ^b   Reed, John C ^a   Fontana, Joseph A ^c   Bost, Frédéric ^d   Hobbs, Peter D ^b   Zheng, Yun ^a   Chen, Guo Quan ^a   Shroot, Braham ^e   Mercola, Dan ^d   Zhang, Xiao Kun ^a  

^a BURNHAM INSTITUTE   (United States)

^b SRI INTERNATIONAL   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d SIDNEY KIMMEL CANCER CENTER   (United States)

^e Ctr Intl de Res Dermatologiques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 [3 (1 ADAMANTYL( 4 HYDROXYPHENYL] 2 NAPHTHALENE CARBOXYLIC ACID; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; RETINOIC ACID; RETINOID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG CANCER; ONCOGENE C JUN; PRIORITY JOURNAL;

EID: 0031830509     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.8.4719     Document Type: Article

References (79)

1. Agadir, A., Y. F. Shealy, D. L. Hill, and X.-K. Zhang. 1997. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells. Cancer Res. 57:3444-3450.
2. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
3. Bernard, B. A., J.-M. Bernardon, C. Delescluse, B. Martin, M.-C. Lenoir, J. Maignan, B. Charpentier, W. R. Pilgrim, U. Reichert, and B. Shroot. 1992. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem. Biophys. Res. Commun. 186:977-983.
4. Bodrug, S. E., C. Aime-Sempe, T. Sato, S. Krajewski, M. Hanada, and J. C. Reed. 1995. Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Growth Differ. 2:173-182.
5. Bossy-Wetzel, E., L. Bakiri, and M. Yaniv. 1997. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16:1695-1709.
6. Bost, F., R. McKay, N. Dean, and D. Mercola. 1997. The Jun kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem. 272:33422-33430.
7. Bullock, G., S. Ray, J. Reed, T. Miyashita, A. M. Ibrado, Y. Huang, and K. Bhalla. 1995. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells. Clin. Cancer Res. 1:559-564.
8. Chang, C., and J. Kokontis. 1988. Identification of a new member of the steroid receptor superfamily by cloning and sequence analysis. Biochem. Biophys. Res. Commun. 155:971-977.
9. Chao, W. R., P. D. Hobbs, L. Jong, X.-K. Zhang, Y. Zheng, Q. Wu, B. Shroot, and M. I. Dawson. 1997. Effects of receptor class-and subtype-selective retinoids and an apoptosis-inducing retinoid on the adherent growth of the NIH:OVCAR-3 ovarian cancer cell line in culture. Cancer Lett. 115:1-7.
10. Clarke, A. R., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper, and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852.
11. Colotta, F., N. Polentarutti, M. Sironi, and A. Mantovani. 1992. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem. 267:18278-18283.
12. WAF1/CIP1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
13. El-Deiry, W., J. W. Harper, P. M. O'Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, K. G. Wiman, W. E. Mercer, M. B. Kastan, K. W. Kohn, S. J. Elledge, K. W. Kinzler, and B. Vogelstein. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169-1174.
14. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Knzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
15. Estus, S., W. J. Zaks, R. S. Freeman, M. Gruda, R. Bravo, and E. M. Johnson. 1994. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 127:1717-1728.
16. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
17. Fisher, D. E. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-542.
18. Forman, B. M., K. Umesono, J. Chen, and R. M. Evans. 1995. Unique response pathways are established by allosteric interactions among receptors. Cell 81:541-550.
19. Freemerman, A. J., J. A. Vrana, R. M. Tombes, H. Jiang, S. P. Chellappan, P. B. Fisher, and S. Grant. 1997. Effects of antisense p21 WAF1/CIP1/MDA6 expression on the induction of differentiation and drug-mediated apoptosis in human myeloid leukemia cells HL-60. Leukemia 11:504-513.
20. Gebert, J. F., N. Moghal, J. V. Frangioni, D. J. Sugarbaker, and B. G. Neel. 1991. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene 6:1859-1868.
21. Gu, Y., C. W. Turek, and D. O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20KD regulatory subunit. Nature 366:707-710.
22. Gudas, L. J., M. B. Sporn, and A. B. Roberts. 1994. Cellular biology and biochemistry of the retinoids, p. 443-520. In M. B. Sporn, A. B. Roberts, and D. S. Goodman (ed.), The retinoids. Raven Press, New York, NY.
23. Ham, J., C. Babij, J. Whitfield, C. M. Pfarr, D. Lallemand, M. Yaniv, and L. L. Rubin. 1995. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 14:927-939.
24. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
25. Hazel, T. G., D. Nathans, and L. F. Lau. 1988. A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc. Natl. Acad. Sci. USA 85:8444-8448.
26. Hennekens, C. H., J. E. Buring, J. E. Manson, M. Stampfer, B. Rosner, N. R. Cook, C. Belanger, F. LaMotte, J. M. Gaziano, P. M. Ridker, W. Willett, and R. Peto. 1996. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N. Engl. J. Med. 334:1145-1149.
27. Hong, W. K., and L. M. Itri. 1994. Retoinoids and human cancer, p. 597-630. In M. B. Sporn, A. B. Roberts, and D. S. Goodman (ed.), The retinoids. Raven Press, New York, NY.
28. L expression and its downregulation by a novel retinoid in breast carcinoma cells. Exp. Cell Res. 232:17-24.
29. Hsu, C. A., A. K. Rishi, X.-S. Li, T. M. Gerald, M. I. Dawson, C. Schiffer, U. Reichert, B. Shroot, G. C. Poirer, and J. A. Fontana. 1997. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood 89:4470-4479.
30. Hunter, T., and J. Pines. 1997. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582.
31. WAF1/CIP1 expression in the absence of p53. Oncogene 9:3397-3406.
32. Kastner, P., M. Mark, and P. Chambon. 1995. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869.
33. Kim, R., and W. T. Beck. 1994. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26. Cancer Res. 54:4958-4966.
34. Korsmeyer, S. J. 1995. Regulators of cell death. Trends Genet. 11:101-105.
35. 34a. Li, Y., M. I. Dawson, A. Agadir, M.-D. Lee, L. Jong, P. D. Hobbs, and X-K. Zhang. 1998. Regulation of RARβ expression by RAR-and RXR-selective retinoids in human lung cancer cell lines: effect on growth inhibition and apoptosis induction. Int. J. Cancer 75:88-95.
36. Liu, Y., M.-O. Lee, H.-G. Wang, Y. Li, Y. Hashimoto, M. Klaus, J. C. Reed, and X.-K. Zhang. 1996. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol. 16:1138-1149.
37. Liu, Z.-G., S. W. Smith, K. A. McLaughlin, L. M. Schwartz, and B. A. Osborne. 1994. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367:281-284.
38. Lowe, S. W., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
39. Lu, X.-P., A. Fanjul, N. Picard, M. Pfahl, D. Rungta, K. Nared-Hood, B. Carter, J. Piedrafita, S. Tang, E. Fabbrizio, and M. Pfahl. 1997. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat. Med. 3:686-690.
40. Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:935-944.
41. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
42. Manome, Y., R. Datta, N. Taneja, T. Shafman, E. Bump, R. Hass, R. Weichselbaum, and D. Kufe. 1993. Coinduction of c-jun gene expression and internucleosomal DNA fragmentation by ionizing radiation. Biochemistry 32:10607-10613.
43. Merritt, A. J., C. S. Potten, C. J. Kemp, J. A. Hickman, A. Balmain, D. P. Lane, and P. A. Hall. 1994. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 54:614-617.
44. Milbrandt, J. 1988. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1:183-188.
45. Miyushita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
46. Noda, A., S. F. Ning, O. M. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
47. Omenn, G. S., G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, A. Glass, J. P. Keogh, F. L. Meyskens, B. Valanis, J. H. Williams, S. Barnhart, and S. Hammar. 1996. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334:1150-1155.
48. Oridate, N., M. Higuchi, S. Suzuki, B. Shroot, W. K. Hong, and R. Lotan. 1997. Induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6-[3-(1-adamantyl)-α-hydroxyphenyl]-2-naphthalene carboxylic acid AHPN/CD437. Int. J. Cancer 70:484-487.
49. Pardee, A. B. 1989. G1 events and regulation of cell proliferation. Science 246:603-608.
50. Cip1 in muscle and other terminally differentiating cells. Science 267:1024-1027.
51. Perlmann, T., and L. Jansson. 1995. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and Nurr1. Genes Dev. 9:769-782.
52. Philips, A., S. Lesage, R. Gingras, J.-H. Maira, Y. Gauthier, P. Hugo, and J. Drouin. 1997. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol. Cell. Biol. 17:5946-5951.
53. Potapova, O., H. Fakhrai, S. Baird, and D. Mercola. 1996. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells. Cancer Res. 56:280-286.
54. Potapova, O., A. Haghighi, F. Bost, C. Liu, M. J. Birrer, R. Gjerset, and D. Mercola. 1997. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272:14041-14044.
55. Reed, J. C. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1-6.
56. Robinson, L. A., L. J. Smith, M. P. Fontaine, H. D. Kay, C. P. Mountjoy, and S. J. Pirruccello. 1995. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Ann. Thorac. Surg. 60:1583-1591.
57. Schadendorf, D., M. A. Kern, M. Artuc, H. L. Pahl, T. Rosenbach, I. Fichtner, W. Nurnberg, S. Stuting, E. von Stebut, M. Worm, A. Makki, K. Jurgovsky, G. Kolde, and B. M. Henz. 1996. Treatment of melanoma cells with the synthetic retinoid AHPN/CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J. Cell Biol. 135:1889-1898.
58. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11:493-504.
59. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
60. Smeal, T., B. Binetruy, D. A. Mercola, M. Birrer, and M. Karin. 1991. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354:494-496.
61. Smeal, T., B. Binetruy, D. Mercola, A. Grover-Bardwick, G. Heidecker, U. R. Rapp, and M. Karin. 1992. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol. Cell. Biol. 12:3507-3513.
62. Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. E. el-Houseini. 1994. Induction of p21 WAF-1/CIP1 during differentiation. Oncogene 9:3389-3396.
63. Steller, H. 1995. Mechanisms and genes of cellular suicide. Science 267:1445-1449.
64. Takahashi, T., M. M. Nau, I. Chiba, M. J. Birrer, R. K. Rosenberg, M. Vinocour, M. Levitt, H. Pass, A. F. Gazdar, and J. D. Minna. 1989. p53: a frequent target for genetic abnormalities in lung cancer. Science 246:491-494.
65. Uemura, H., A. Mizokami, and C. Chang. 1995. Identification of a new enhancer in the promoter region of human TR3 orphan member of steroid receptor superfamily. J. Biol. Chem. 270:5427-5433.
66. van Dam, H., D. Wilhelm, I. Herr, A. Steffen, P. Herrlich, and P. Angel. 1995. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14:1798-1811.
67. Vogt, P., and T. J. Bos. 1990. Jun: oncogene and transcription factor. Cancer Res. 55:1-35.
68. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15.
69. Widschwendter, M., G. Daxenbichler, Z. Culig, S. Michel, A. G. Zeimet, M. G. Mortl, A. Widschwendter, and C. Marth. 1997. Activity of retinoic acid receptor-γ selectively binding retinoids alone and in combination with interferon-γ in breast cancer cell lines. Int. J. Cancer 71:497-504.
70. Williams, G. T., and L. F. Lau. 1993. Activation of the inducible orphan receptor gene nur77 by serum growth factors: dissociation of immediate-early and delayed-early responses. Mol. Cell. Biol. 13:6124-6136.
71. Wilson, T. E., T. J. Fahrner, M. Johnston, and J. Milbrandt. 1991. Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science 252:1296-1300.
72. Woronicz, J. D., B. Cainan, V. Ngo, and A. Winoto. 1994. Requirement for the orphan steroid receptor nur77 in apoptosis of T-cell hybridomas. Nature 367:277-281.
73. Wu, Q., Y. Li, R. Liu, A. Agadir, M.-O. Lee, Y. Liu, and X.-K. Zhang. 1997. Modulation of retinoic acid sensitivity in lung cancer cells by a dynamic balance of nur77 and COUP-TF orphan receptors and their heterodimerization. EMBO J. 16:1656-1669.
74. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
75. Yang-Yen, H. F., X.-K. Zhang, G. Graupner, M. Tzukerman, B. Sakamoto, M. Karin, and M. Pfahl. 1991. Antagonism between retinoic acid receptors and AP-1: implications for tumor promotion and inflammation. New Biol. 3:1206-1219.
76. WAF1/CIP1 expression by p53-independent pathways. Oncogene 12:1557-1564.
77. Zhang, X.-K., B. Hoffmann, P. B. Tran, G. Graupner, and M. Pfahl. 1992. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355:441-446.
78. Zhang, X.-K., and M. Pfahl. 1993. Regulation of retinoid and thyroid hormone action through homodimeric and heterodimeric receptors. Trends Endocrinol. Metab. 4:156-162.
79. Zhang, X.-K., Y. Liu, M.-O. Lee, and M. Pfahl. 1994. A specific defect in the retinoic acid receptor associated with human lung cancer cell lines. Cancer Res. 54:5663-5669.